ICON plc, (NASDAQ: ICLR) a world-leading clinical research organization, today announced that it will release its financial results for the first quarter 2026 after the market closes on Tuesday, June ...
Earnings call ICON delivered Q4 2025 revenue of $2.1B (+2.5% YoY), with full-year revenue up 0.8% to $5B. Adjusted EBITDA margin fell to 15.5% in Q4 due to investigation-related adjustments and higher ...
DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that it will release financial results for the fourth ...
ICON plc (NASDAQ: ICLR), a world-leading clinical research organization, today announced that it will release financial results for the fourth quarter and full year 2025 results after the market ...
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organization, today announced that it will release its financial results for the first quarter 2026 after the market closes on Tuesday, June ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results